Detalhe da pesquisa
1.
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?
Allergy
; 77(11): 3293-3308, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852798
2.
Pediatric asthma: An unmet need for more effective, focused treatments.
Pediatr Allergy Immunol
; 30(1): 7-16, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312503
3.
Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs.
Eur Respir J
; 57(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675208
4.
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
JAMA
; 309(11): 1125-35, 2013 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23478743
5.
Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
Respir Med
; 217: 107334, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392789
6.
Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.
J Allergy Clin Immunol Pract
; 11(3): 896-905, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581073
7.
Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL.
World Allergy Organ J
; 16(6): 100787, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37332525
8.
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.
World Allergy Organ J
; 16(6): 100788, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389200
9.
Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis.
J Allergy Clin Immunol Pract
; 11(4): 1134-1146, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529441
10.
Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma.
World Allergy Organ J
; 15(10): 100695, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254180
11.
Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies.
J Allergy Clin Immunol Pract
; 9(7): 2702-2714, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486142
12.
Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence.
World Allergy Organ J
; 14(3): 100519, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33815652
13.
Ligelizumab treatment for severe asthma: learnings from the clinical development programme.
Clin Transl Immunology
; 10(3): e1255, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33747510
14.
Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
World Allergy Organ J
; 13(9): 100460, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983330
15.
Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study.
World Allergy Organ J
; 13(12): 100469, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611470
16.
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
J Allergy Clin Immunol Pract
; 7(5): 1418-1429, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928481